Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells. [electronic resource]
Producer: 19920918Description: 1600-6 p. digitalISSN:- 0006-291X
- Antineoplastic Agents -- pharmacology
- Cell Line
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Humans
- IMP Dehydrogenase -- antagonists & inhibitors
- Kinetics
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Molecular Structure
- Nucleosides -- pharmacology
- Ribavirin -- analogs & derivatives
- Ribonucleotides -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.